D
Dunyue Lu
Researcher at State University of New York System
Publications - 44
Citations - 8807
Dunyue Lu is an academic researcher from State University of New York System. The author has contributed to research in topics: Traumatic brain injury & Bone marrow. The author has an hindex of 41, co-authored 44 publications receiving 8475 citations. Previous affiliations of Dunyue Lu include Henry Ford Hospital & Henry Ford Health System.
Papers
More filters
Journal ArticleDOI
Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats
TL;DR: MSCs delivered to ischemic brain tissue through an intravenous route provide therapeutic benefit after stroke and may provide a powerful autoplastic therapy for stroke.
Journal ArticleDOI
Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation.
TL;DR: The data suggest that transplantation of MSCs may have a therapeutic role after spinal cord injury, and indicate significant improvement in functional outcome in animals treated with MSC transplantation compared to control animals.
Journal ArticleDOI
Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat
Jieli Chen,Yi Li,Mark Katakowski,Mark Katakowski,Xiaoguang Chen,Lei Wang,Dunyue Lu,Mei Lu,Subhash C. Gautam,Michael Chopp,Michael Chopp +10 more
TL;DR: It is demonstrated that intravenously administered male MSCs increase bFGF expression, reduce apoptosis, promote endogenous cellular proliferation, and improve functional recovery after stroke in female rats.
Journal ArticleDOI
Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells.
TL;DR: It is suggested that hMSCs may be a potential therapy for patients who have sustained traumatic brain injuries and significantly improved the rats’ functional outcomes.
Journal ArticleDOI
Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells
Yi Li,Jieli Chen,Chun Ling Zhang,Lei Wang,Dunyue Lu,Mark Katakowski,Mark Katakowski,Qi Gao,Li Hong Shen,Jing Zhang,Mei Lu,Michael Chopp,Michael Chopp +12 more
TL;DR: This is the first report to show that MSCs injected at 7 days after stroke improve long-term neurological outcome in older animals, and reactive astrocytes responding to MSC treatment of ischemia may also promote axonal regeneration during long‐term recovery.